From Verify.Wiki
Jump to: navigation, search

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

QuickUpload1048 20170727120829.jpg
Type Public
Founded 1988
Headquarters New York, New York
Number of employees 51-200 employees



Top 5 Recent Tweets

April 20, 2021BWayynne@CoronaTurd Yeah was being generous there by limiting it to the time it was under CYDY control. Story for another d…
April 16, 2021ProgenicsCBWhen you choose Progenics, you can get the most out of your #cordblood. We have always successfully generated a hig…
April 07, 2021urotodayThe biology of #ProstateCancer metastasis and what #PSMAImaging is teaching us. Presentation by @pienta_brady…

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history